Buy Tesamorelin 6mg/Ipamorelin 2mg Blend Research Peptide OnlineTesamorelin/ipamorelin blend (6mg:2mg ratio, 8mg total) emphasizes GHRH-pathway modulation with supplementary GHS-R activation for comprehensive preclinical research into combined somatotropic axis mechanisms. The 3:1 ratio enables detailed investigation of GHRH-dominant dual-pathway growth hormone stimulation models.Tesamorelin 6mg/Ipamorelin 2mg Blend Peptide Identification & CompositionTesamorelin (6mg): 44-amino acid GHRH agonist with enhanced proteolytic stability and receptor binding. Ipamorelin (2mg): pentapeptide GHS-R1a agonist. The 3:1 molar ratio provides primary GHRH signaling with secondary ghrelin-receptor engagement, supporting research into axis-level growth hormone regulation mechanisms in controlled systems.Tesamorelin 6mg/Ipamorelin 2mg Blend Mechanism of Action in Preclinical SystemsTesamorelin dominantly engages GHRH receptors on pituitary somatotrophs, promoting primary growth hormone secretion. Ipamorelin activates complementary GHS-R1a pathways. Combined mechanisms produce synergistic growth hormone secretion in preclinical models. Research documents that this specific ratio provides robust growth hormone elevation while maintaining GHRH-pathway dominance in controlled investigation settings.Tesamorelin 6mg/Ipamorelin 2mg Blend Published Research SummaryLiterature in Endocrinology and Neuroendocrinology documents individual peptide effects extensively in preclinical models. Research demonstrates synergistic growth hormone secretion when GHRH and GHS-R agonists combine in animal systems. Preclinical studies support investigation of this peptide combination for understanding multi-pathway somatotropic regulation mechanisms.Tesamorelin 6mg/Ipamorelin 2mg Blend Product Specifications & Handling– Form: Lyophilized powder blend (acetate salts) – Quantity: 6mg tesamorelin 2mg ipamorelin (8mg total) – Molar Ratio: 3:1 (GHRH-dominant) – Purity: Research-grade (98% ) – Storage: -20°C freezer; protect from light and moisture – Reconstitution: Sterile saline or bacteriostatic water; room temperature equilibration – Stability: 2-3 weeks refrigerated post-reconstitutionTesamorelin 6mg/Ipamorelin 2mg Blend Research Use Only DisclaimerThis blend is intended exclusively for preclinical research and laboratory investigation. Not approved for human consumption, veterinary use, or clinical application. All use must comply with institutional research protocols.
